BRAF: A Driver of the Serrated Pathway in Colon Cancer
- 1 July 2013
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 24 (1) , 1-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A Genetic Progression Model of BrafV600E-Induced Intestinal Tumorigenesis Reveals Targets for Therapeutic InterventionCancer Cell, 2013
- Resistance to BRAF-targeted therapy in melanomaEuropean Journal of Cancer, 2013
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFRNature, 2012
- Mutant Kras Promotes Hyperplasia and Alters Differentiation in the Colon Epithelium but Does Not Expand the Presumptive Stem Cell PoolGastroenterology, 2011
- Molecular Genetics of Colorectal CancerAnnual Review of Pathology: Mechanisms of Disease, 2011
- Ink4a/Arf and Oncogene-Induced Senescence Prevent Tumor Progression during Alternative Colorectal TumorigenesisCancer Cell, 2010
- Role of the Serrated Pathway in Colorectal Cancer PathogenesisGastroenterology, 2010
- The genetics of hereditary colon cancerGenes & Development, 2007
- Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in miceGastroenterology, 2002